Influence of Antigen Type on the Establishment of an Induced Sjögren Syndrome Mouse Model

doi:10.12300/j.issn.1674-5817.2025.175

Abstract

Abstract:

Objective This study aims to compare the modeling effects of submaxillary gland antigen and salivary gland antigen in the establishment of Sj?gren syndrome (SS) mouse models, and to characterize the phenotypic and immunological features of these models in comparison with spontaneous SS-prone non-obese diabetic (NOD)/LtJ mice. Methods Adult C57BL/6J mice (equal numbers of males and females) were immunized with submaxillary gland antigen or salivary gland antigen, respectively, combined with Freund's adjuvant to induce SS models. Mice immunized with phosphate-buffered saline (PBS) combined with Freund's adjuvant served as the control group. Immunization was induced via multiple subcutaneous injections in the back with antigen combined with Freund's complete adjuvant (FCA) on Days 1 and 7. A booster immunization was administered via multiple subcutaneous injections in the back with antigen combined with Freund's incomplete adjuvant (FIA) on Day 14. Female NOD/LtJ mice were used as the spontaneous SS model group, with ICR mice as the corresponding control strain for comparative analysis. Body weight, water intake, and salivary flow rate of mice were dynamically monitored for 4 weeks. At the end of the experiment, tissue and serum samples were collected, the weights of submaxillary glands, thymus, and spleen were measured, and organ indices (organ-to-body weight ratios) were calculated. Pathological morphological analysis of the submaxillary gland and spleen was performed with hematoxylin and eosin (HE) staining. Serum interleukin-17 (IL-17) level was detected using enzyme-linked immunosorbent assay (ELISA). Real-time quantitative polymerase chain reaction was used to detect the mRNA expression levels of SS type A (SSA) and SS type B (SSB) in submaxillary gland tissues. Results Female mice in the submaxillary gland antigen group exhibited significantly increased water intake (P<0.05) and reduced salivary flow rate (P<0.05) compared with the female control group. No statistically significant differences were observed in the submaxillary gland index, thymus index and spleen index (P>0.05). Focal lymphocytic infiltration was observed in the submaxillary glands, and the splenic marginal zone was enlarged. Serum IL-17 levels were significantly increased (P<0.05). There was no significant difference in submaxillary gland SSA/SSB expression levels (P>0.05). Compared with the female control group, female mice in the salivary gland antigen group showed no statistically significant differences in water intake, salivary flow rate, submaxillary gland index, and spleen index (P>0.05), whereas the thymus index was significantly reduced (P<0.01). Mild inflammatory cell infiltration and glandular atrophy were observed in the submaxillary glands, and the splenic white pulp and marginal zone were slightly enlarged. Serum IL-17 levels and submaxillary gland SSB mRNA expression levels were significantly increased (P<0.01), whereas no significant change was observed in submaxillary gland SSA expression levels (P>0.05). Compared with the male control group, mild submaxillary gland atrophy was observed in male mice in the submaxillary gland antigen group, whereas no obvious changes were found in other modeling-related indicators (P>0.05). Compared with the ICR control group, NOD/LtJ model mice exhibited elevated water intake (P<0.05), significantly reduced salivary flow rate (P<0.01), no significant differences in the submaxillary gland index or spleen index (P>0.05), but a significantly increased thymus index (P<0.05). Marked focal infiltration was observed in the submaxillary glands, the splenic marginal zone was obviously enlarged, and serum IL-17 concentrations as well as submaxillary gland SSA/SSB expression levels were significantly increased (P<0.05). Conclusion Submaxillary gland antigen and salivary gland antigen can induce SS-related features in female C57BL/6J mice. The SS-related phenotype is more pronounced in the submaxillary gland antigen group than in the salivary gland antigen group, but weaker than that in spontaneously SS-prone female NOD/LtJ mice. Immunization of male C57BL/6J mice with submaxillary or salivary gland antigens fails to induce an obvious SS phenotype.

Key words: Sj?gren syndrome, Submaxillary gland antigen, Salivary gland antigen, C57BL/6J mice, NOD/LtJ mice

CLC Number:

Q95-33

RONG Wenshuang,NIU Yuanfei,LIU Meiting,et al. Influence of Antigen Type on the Establishment of an Induced Sjögren Syndrome Mouse Model[J]. Laboratory Animal and Comparative Medicine, 2026, 46(2): 178-190. DOI: 10.12300/j.issn.1674-5817.2025.175.

Figures/Tables 7

References 25

[1]	刘维, 何东仪, 张文, 等. 干燥综合征中西医结合诊疗指南[J]. 中草药, 2025, 56(15): 5333-5346. DOI: 10.7501/j.issn.0253-2670.2025.15.001 .
	LIU W, HE D Y, ZHANG W, et al. Guideline for diagnosis and treatment of Sjögren's syndrome with integrated traditional Chinese and Western medicine[J]. Chin Tradit Herb Drugs, 2025, 56(15): 5333-5346. DOI: 10.7501/j.issn.0253-2670.2025.15.001 .
[2]	张欢, 刘春红, 吴斌. 原发性干燥综合征的流行病学研究进展[J]. 现代预防医学, 2020, 47(16): 3056-3058, 3063. DOI: 10.20043/j.cnki.mpm.2020.16.041 .
	ZHANG H, LIU C H, WU B. Advances in the epidemiology of primary Sjögren's syndrome[J]. Mod Prev Med, 2020, 47(16): 3056-3058, 3063. DOI: 10.20043/j.cnki.mpm.2020.16.041 .
[3]	FAIRWEATHER D, BEETLER D J, MCCABE E J, et al. Mechanisms underlying sex differences in autoimmunity[J]. J Clin Investig, 2024, 134(18): e180076. DOI: 10.1172/jci180076 .
[4]	GAO Y Z, CHEN Y, ZHANG Z J, et al. Recent advances in mouse models of Sjögren's syndrome[J]. Front Immunol, 2020, 11: 1158. DOI: 10.3389/fimmu.2020.01158 .
[5]	JIANG T T, LIU X Q, WANG S M, et al. Paeoniflorin alleviated experimental Sjögren's syndrome by inhibiting NLRP3 inflammasome activation of submandibular gland cells via activating Nrf2/HO-1 pathway[J]. Free Radic Biol Med, 2025, 233: 355-364. DOI: 10.1016/j.freeradbiomed.2025.03.043 .
[6]	LIN X, RUI K, DENG J, et al. Th17 cells play a critical role in the development of experimental Sjögren's syndrome[J]. Ann Rheum Dis, 2015, 74(6): 1302-1310. DOI: 10.1136/annrheumdis-2013-204584 .
[7]	BAGAVANT H, DURSLEWICZ J, PYCLIK M, et al. Age-associated B cell infiltration in salivary glands represents a hallmark of Sjögren's-like disease in aging mice[J]. Geroscience, 2024, 46(6): 6085-6099. DOI: 10.1007/s11357-024-01159-3 .
[8]	XU J J, LIU O S, WANG D D, et al. In vivo generation of SSA/ro antigen-specific regulatory T cells improves experimental Sjögren's syndrome in mice[J]. Arthritis Rheumatol, 2022, 74(10): 1699-1705. DOI: 10.1002/art.42244 .
[9]	ARVIDSSON G, CZARNEWSKI P, JOHANSSON A, et al. Multimodal single-cell sequencing of B cells in primary Sjögren's syndrome[J]. Arthritis Rheumatol, 2024, 76(2): 255-267. DOI: 10.1002/art.42683 .
[10]	LEE A Y S, PUTTY T, LIN M W, et al. Isolated anti-Ro52 identifies a severe subset of Sjögren's syndrome patients[J]. Front Immunol, 2023, 14: 1115548. DOI: 10.3389/fimmu.2023. 1115548 .
[11]	WU Y, PENG L, FENG P Y, et al. Gut microbes consume host energy and reciprocally provide beneficial factors to sustain a symbiotic relationship with the host[J]. Sci Total Environ, 2023, 904: 166773. DOI: 10.1016/j.scitotenv.2023.166773 .
[12]	LUO Y, ZENG L T, WANG Y N, et al. Artemisinin derivatives modulate KEAP1-NRF2-xCT pathway to alleviate Sjögren's disease: insights from scRNA-seq and systems biology[J]. Front Immunol, 2025, 16: 1626230. DOI: 10.3389/fimmu. 2025. 1626230 .
[13]	贵州省中西医结合学会. 2016ACR/EULAR共识: 原发性干燥综合征的最新分类标准[C/OL]//2019年贵州省中医、中西医结合风湿病学术会议论文集. (2019-04-26)[2025-10-23]. .
	Guizhou Provincial Association of Integrated Traditional Chinese and Western Medicine. 2016ACR/EULAR consensus: updated classification criteria for primary Sjögren's syndrome[C/OL]//Proceedings of the 2019 Guizhou Provincial Conference on Rheumatology in Traditional Chinese Medicine and Integrated Traditional and Western Medicine. (2019-04-26)[2025-10-23]. .
[14]	VAN GINKEL M S, NAKSHBANDI U, ARENDS S, et al. Increased diagnostic accuracy of the labial gland biopsy in primary Sjögren syndrome when multiple histopathological features are included[J]. Arthritis Rheumatol, 2024, 76(3): 421-428. DOI: 10.1002/art.42723 .
[15]	MATSUI K, SANO H. T helper 17 cells in primary Sjögren's syndrome[J]. J Clin Med, 2017, 6(7): 65. DOI: 10.3390/jcm 6070065 .
[16]	ZHAN Q P, ZHANG J N, LIN Y B, et al. Pathogenesis and treatment of Sjogren's syndrome: Review and update[J]. Front Immunol, 2023, 14: 1127417. DOI: 10.3389/fimmu. 2023. 1127417 .
[17]	FLOREZI G P, BARONE F P, PELISSARI C, et al. Salivary Th17-associated cytokines as potential biomarkers in primary Sjögren's disease[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2025, 140(4): 428-435. DOI: 10.1016/j.oooo.2025.04.171 .
[18]	郭朝焱. 病理诊断要点与应用[M]. 南昌: 江西科学技术出版社, 2023.
	GUO C Y. Key points and applications of pathological diagnosis[M]. Nanchang: Jiangxi Science and Technology Press, 2023.
[19]	YAO Y, MA J F, CHANG C, et al. Immunobiology of T cells in Sjögren's syndrome[J]. Clin Rev Allergy Immunol, 2021, 60(1): 111-131. DOI: 10.1007/s12016-020-08793-7 .
[20]	ROBERT P A, ARULRAJ T, MEYER-HERMANN M. Germinal centers are permissive to subdominant antibody responses[J]. Front Immunol, 2024, 14: 1238046. DOI: 10.3389/fimmu. 2023.1238046 .
[21]	PASUPULETI D, BAGWE P, FERGUSON A, et al. Evaluating nanoparticulate vaccine formulations for effective antigen presentation and T-cell proliferation using an in vitro overlay assay[J]. Vaccines, 2024, 12(9): 1049. DOI: 10.3390/vaccines 12091049 .
[22]	TURNER J D, TSAPPARELLI J, GILLIGAN L C, et al. Hormonal risk factors and androgen and glucocorticoid dysregulation in Sjogren's disease and non-Sjogren's sicca[J]. Rheumatology, 2026, 65: keaf546. DOI: 10.1093/rheumatology/keaf546 .
[23]	CHATZIS L G, GOULES A V, TZIOUFAS A G. Searching for the ″X factor″ in Sjögren's syndrome female predilection[J]. Clin Exp Rheumatol, 2021, 39(6): 206-214. DOI: 10.55563/clinexprheumatol/88dyrn .
[24]	陈冬志, 赵会娟, 尹晓琳, 等. NOD/LtJ小鼠Ⅰ型糖尿病不同发病阶段细胞免疫状态研究[J]. 中国免疫学杂志, 2019, 35(5): 526-533. DOI: 10.3969/j.issn.1000-484X.2019.05.003 .
	CHEN D Z, ZHAO H J, YIN X L, et al. Study on cellular immune status of NOD/LtJ mice at different stages of typeⅠdiabetes[J]. Chin J Immunol, 2019, 35(5): 526-533. DOI: 10.3969/j.issn.1000-484X.2019.05.003 .
[25]	WONG F S, PEARSON J A, WEN L. Is the NOD mouse a good model for type 1 diabetes?[J]. Diabetologia, 2026, 69(1): 3-19. DOI: 10.1007/s00125-025-06579-0 .

引物名称 Primer name	引物序列 Primer sequence
m-SSA-F	5'-GCTGGTCTCACAAAGATCTCCTCC-3'
m-SSA-R	5'-TCTCAGCCTCCACAGAAAGCG-3'
m-SSB-F	5'-ATGACTGCTTTGGAGGCCAAAATC-3'
m-SSB-R	5'-TGTCAGCCGGTTTAGCCTGTTGAA-3'
m-β-Actin-F	5'-AGAGGGAAATCGTGCGTGAC-3'
m-β-Actin-R	5'-CAATAGTGATGACCTGGCCGT-3'

引物名称 Primer name	引物序列 Primer sequence
m-SSA-F	5'-GCTGGTCTCACAAAGATCTCCTCC-3'
m-SSA-R	5'-TCTCAGCCTCCACAGAAAGCG-3'
m-SSB-F	5'-ATGACTGCTTTGGAGGCCAAAATC-3'
m-SSB-R	5'-TGTCAGCCGGTTTAGCCTGTTGAA-3'
m-β-Actin-F	5'-AGAGGGAAATCGTGCGTGAC-3'
m-β-Actin-R	5'-CAATAGTGATGACCTGGCCGT-3'